Skyler Bloom | Director, Business Development & Corporate Strategy |
Adam Grossman | President and CEO |
Brian Lenz | EVP & CFO |
Elliot Wilbur | Raymond James |
Kristen Kluska | Cantor Fitzgerald |
Zach Weiner | Jefferies |
Good afternoon, and welcome to the ADMA Biologics Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call on Thursday, March 24, 2022. [Operator Instructions] Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours following the end of the call.
At this time, I'd like to introduce Skyler Bloom, Senior Director of Business Development and Corporate Strategy at ADMA Biologics. Please go ahead.
Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics' financial results for the fourth quarter and full year 2021 and recent corporate updates.